ClinicalTrials.gg
RecruitingNCT07455461StimNovoLearnUpdated Mar 6, 2026

Cortical Excitability During de Novo Motor Learning

An interventional study of De novo motor learning in Motor Learning and Corticospinal Excitability, sponsored by Universite du Littoral Cote d'Opale. Recruiting at 1 site in France. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-06.

Sponsored by Universite du Littoral Cote d'Opale · Not applicable, Interventional, and Basic science

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
18 Years to 35 Years
Sex
All
01

Study summary

De novo motor learning is a specific learning paradigm that allows investigation of how a new motor skill is learned from scratch. Motor task learning can induce increased corticospinal excitability and reorganization of connectivity observed within the motor cortex (M1). Several studies have investigated the plasticity mechanisms underlying motor learning using simple paradigms. The results obtained have been variable, with a major trend toward increased corticospinal excitability, while other results show no increase. We expect to observe a significant increase in excitability and enhanced intracortical reorganization mechanisms within M1 in our subjects during our de novo motor learning sessions.

The primary objective of this study is to measure changes in corticospinal excitability of the motor system across 3 de novo motor learning sessions separated by different time intervals.

The secondary objectives will be: 1) to measure learning across the three practice sessions, 2) to measure changes in inhibition and facilitation across the 3 learning sessions, and 3) to measure correlations between subjects' motor performance and corticospinal and intracortical changes.

02

Conditions studied

  • Motor Learning
  • Corticospinal Excitability
03

In context

Lead sponsor

Universite du Littoral Cote d'Opale is the lead sponsor of 11 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • right-handed
  • healthy
  • having signed an form

Exclusion criteria

Exclusion Criteria:

  • counter-indication to transcranial magnetic stimulation
  • pregnancy
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Motor learning

    Subjects follow a de novo motor learning protocol

    Behavioral: De novo motor learning

Interventions

  • BehavioralDe novo motor learning

    Subjects will follow 3 sessions of de-novo motor learning (days 1, 2, 8)

06

What researchers measure

Primary outcomes

  1. Change in Motor Evoked Potential (MEP) Amplitude Input-Output Curve Assessed by Single-Pulse TMS

    Motor Evoked Potential amplitude (mV) recorded from the target muscle (Abductor Pollicis Brevis) in response to increasing TMS intensities. The parameters of the sigmoid input-output curve will be calculated using a Boltzmann function fit.

    Time frame: Baseline (Day 1, pre-session), immediately post-session on Day 1, pre-session on Day 2, immediately post-session on Day 2, pre-session on Day 9, and immediately post-session on Day 9

  2. Change in Short-Interval Intracortical Inhibition (SICI) Assessed by Paired-Pulse TMS

    Conditioned MEP amplitude expressed as a ratio of unconditioned MEP amplitude (%), using a conditioning stimulus at 80% RMT and inter-stimulus interval of 3 ms.

    Time frame: Baseline (Day 1, pre-session), immediately post-session on Day 1, pre-session on Day 2, immediately post-session on Day 2, pre-session on Day 9, and immediately post-session on Day 9

  3. Change in Long-Interval Intracortical Inhibition (LICI) Assessed by Paired-Pulse TMS

    Conditioned MEP amplitude as a ratio of unconditioned MEP amplitude (%), using a conditioning stimulus at suprathreshold intensity and inter-stimulus interval of 100ms.

    Time frame: Baseline (Day 1, pre-session), immediately post-session on Day 1, pre-session on Day 2, immediately post-session on Day 2, pre-session on Day 9, and immediately post-session on Day 9

  4. Change in Intracortical Facilitation (ICF) Assessed by Paired-Pulse TMS

    Conditioned MEP amplitude as a ratio of unconditioned MEP amplitude (%), using a conditioning stimulus at 80% RMT and an inter-stimulus interval of 10ms.

    Time frame: Baseline (Day 1, pre-session), immediately post-session on Day 1, pre-session on Day 2, immediately post-session on Day 2, pre-session on Day 9, and immediately post-session on Day 9

Secondary outcomes

  1. Change in Motor Learning Performance Assessed by Movement Path Length During a 3D Finger-Cursor Task

    Path length (mm) of the cursor trajectory during each trial of the motor learning task. Shorter path length indicates more efficient, learned movement.

    Time frame: During each motor learning session on Day 1, Day 2, and Day 9

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Feb 2026; primary completion for Jun 2027, 16 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 19, 2026
First posted
Mar 6, 2026
StartEst.
Feb 25, 2026
Primary completionEst.
Jun 2027
CompletionEst.
Jun 2027
Last update
Mar 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07455461
Lead sponsor
Universite du Littoral Cote d'Opale
Responsible party
Sponsor
First posted
Mar 6, 2026
Start date
Feb 25, 2026 (estimated)
Primary completion
Jun 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
Mar 6, 2026

Study contacts

Pierre D Morel, Dr
Contact
pierre.morel@univ-littoral.fr
0033781692692

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion